GAM
GBT

Gemmer Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Gemmer Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3
Closed – – 1454
2019
Q3 		$0 Buy
+3
New +$156 ﹤0.01% 1496

Other funds holding GBT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gemmer Asset Management's GBT Position: Q4 2019 in Review

Gemmer Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2019, closing a stake of 3 shares.

Gemmer Asset Management first reported a position in GBT in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

  • Gemmer Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Gemmer Asset Management sold 3 Global Blood Therapeutics, Inc. shares in Q4 2019.
  • Gemmer Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 1 quarter.
  • Gemmer Asset Management's Global Blood Therapeutics, Inc. position peaked at $0 in Q3 2019.
  • 234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.